Eliem Therapeutics Inc (ELYM)
8.17
-0.01
(-0.12%)
USD |
NASDAQ |
May 17, 16:00
8.17
0.00 (0.00%)
Pre-Market: 20:00
Eliem Therapeutics Accounts Payable (Quarterly): 0.085M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.085M |
| December 31, 2023 | 0.066M |
| September 30, 2023 | 0.736M |
| June 30, 2023 | 0.878M |
| March 31, 2023 | 0.864M |
| December 31, 2022 | 0.75M |
| September 30, 2022 | 1.494M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.061M |
| March 31, 2022 | 0.847M |
| December 31, 2021 | 1.404M |
| September 30, 2021 | 2.579M |
| June 30, 2021 | 1.955M |
| March 31, 2021 | 2.003M |
| December 31, 2020 | 1.086M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.066M
Minimum
Dec 2023
2.579M
Maximum
Sep 2021
1.129M
Average
0.9695M
Median
Accounts Payable (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 4.17M |
| Candel Therapeutics Inc | 0.472M |
| Cyclacel Pharmaceuticals Inc | 3.543M |
| Lipocine Inc | 0.6714M |
| GlycoMimetics Inc | 0.7555M |